Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2007 Oct 8;51(12):4508–4511. doi: 10.1128/AAC.00317-07

Extensive Genetic Diversity in the Plasmodium falciparum Na+/H+ Exchanger 1 Transporter Protein Implicated in Quinine Resistance

Sumiti Vinayak 1, Mohammad Tauqeer Alam 1, Mala Upadhyay 1, Manoj K Das 2, Vas Dev 3, Neeru Singh 4, Aditya P Dash 5, Yagya D Sharma 1,*
PMCID: PMC2167966  PMID: 17923493

Abstract

The Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) locus at chromosome 13 and another locus at chromosome 9 have recently been proposed to influence quinine resistance. Here, we sequenced the ms4760 locus of the Pfnhe-1 gene from 244 P. falciparum isolates collected from five different regions of India. A total of 16 different ms4760 alleles (with one to five DNNND repeats) were observed among these isolates. Interestingly, areas with a high prevalence of chloroquine and sulfadoxine-pyrimethamine resistance showed more Pfnhe-1 DNNND repeats compared to low drug resistance areas. The extent of genetic diversity at the ms4760 locus also varied from one region to another, with expected heterozygosity values ranging from 0.47 to 0.88.


The emergence and spread of resistance in Plasmodium falciparum against the two most commonly used antimalarial drugs, chloroquine (CQ) and sulfadoxine-pyrimethamine (SP), has resulted in an increased use of quinine (QN) (6, 11). This is because QN is not only used to treat severe and complicated malaria cases but is also used to treat patients who do not respond to CQ and SP treatment. While the genetic basis of CQ and SP resistance in the parasite is known in great detail (17), the same is still evolving for QN resistance (7, 8). The possible involvement of the P. falciparum Na+/H+ exchanger (Pfnhe-1) membrane transporter at chromosome 13, along with another locus at chromosome 9, in QN resistance has recently been proposed (8, 9). We describe here the genetic variation in the cytoplasmic domain of the Pfnhe-1 protein containing DNNND repeats (ms4760 locus) among Indian isolates.

The P. falciparum isolates used in this study were collected during 2004 and 2005 from Panna (Madhya Pradesh [MP]; n = 45), Ghaziabad and Aligarh (Uttar Pradesh [UP]; n = 50), Car Nicobar (Andaman and Nicobar [A & N] Islands; n = 55), Kamrup (Assam; n = 74), and Cuttack (Orissa; n = 20) (Fig. 1). Patients attending malaria clinics were screened for the presence of malaria parasites by light microscopy and treated with antimalarial drugs as described earlier (4), in accordance with the national drug policy of India prevalent in the region (http://www.nvbdcp.gov.in). About 200 μl of heparinized blood was collected from P. falciparum-positive individuals. Blood collections were done in accordance with institutional ethical guidelines. Parasite DNA was extracted in accordance with the protocols described earlier (18). An aliquot was used to amplify the ms4760 locus of the Pfnhe-1 gene with primers NHE-A (5′-AGTCGAAGGCGAATCAGATG-3′) and NHE-B (5′-GATACTTACGAACATGTTCATG-3′) and standard PCR cycling parameters (18). Primers NHE-C (5′-ATCCCTGTTGATATATCGAATG-3′) and NHE-D (5′-TTGTCATTAGTACCCTTAGTTG-3′) were used for nested PCR. Both strands of the PCR product were sequenced with primers NHE-C and NHE-D by the protocols described earlier (18).

FIG. 1.

FIG. 1.

Map of India showing the sample collection sites.

Sequencing of the ms4760 locus of the nhe-1 gene from 244 P. falciparum isolates revealed extensive polymorphisms at this locus (Fig. 2) with an overall calculated heterozygosity (He) value of 0.79. The level of genetic variation among the isolates from UP and MP was relatively lower than that of the isolates from Assam, Orissa, and the A & N Islands (Table 1). A total of 16 different ms4760 genotypes of Pfnhe-1 were observed among these isolates. This includes 5 of 8 already reported Pfnhe-1 genotypes besides 11 newer genotypes (8). The frequency of occurrence of these genotypes varied among the regions (Table 1). Genotypes ms4760-2, ms4760-4, and ms4760-8, reported by Ferdig et al. (8), were not detected among our Indian isolates. Genotypes ms4760-3 and ms4760-6 were present in all five regions (Table 1). A maximum of 12 genotypes were found in Assam, while UP had only 3 genotypes.

FIG. 2.

FIG. 2.

Multiple amino acid sequence alignments of 19 ms4760 genotypes. The genotypes ms4760-2, ms4760-4, and ms4760-8 are from Ferdig et al. (8), while the rest of them are from this study. Block I represents a DNN repeat, block II represents DNNND repeats, block III is characterized by insertion and deletion of NHND residues, block IV shows insertion and deletion of the amino acids DKNNKND, block V represents DDNHNDNHNND repeats, and block VI represents DDNNNDNHNDD repeats. All other variations are highlighted. Gaps were created in order to maximize the alignment. The designations on left are microsatellite genotypes, and the numbers on right are positions of amino acids. The electropherograms were analyzed with the BioEdit Sequence Alignment Editor (10), and sequences were aligned with the GeneDoc Multiple Sequence Alignment Editor and Shading Utility (version 2.6.002).

TABLE 1.

Regional distribution of Pfnhe-1 ms4760 genotypes among Indian isolates

Genotypea or parameter No. of DNNND repeats (His/Asp ratio)b No. of isolates (allelic frequency)
Total (n = 244)
MP (n = 45)c UP (n = 50) A & N (n = 55) Assam (n = 74) Orissa (n = 20)
ms4760-1 2 (7:4) 3 (0.066) 4 (0.072) 6 (0.081) 3 (0.15) 16 (6.55)
ms4760-3 1 (6:2) 7 (0.155) 17 (0.340) 12 (0.218) 8 (0.108) 1 (0.05) 45 (18.44)
ms4760-5 4 (5:8) 1 (0.022) 2 (0.036) 1 (0.05) 4 (1.630)
ms4760-6 2 (5:4) 32 (0.711) 28 (0.560) 6 (0.109) 16 (0.216) 6 (0.30) 88 (36.06)
ms4760-7 3 (5:6) 27 (0.490) 17 (0.229) 3 (0.15) 47 (19.62)
ms4760-9 3 (7:6) 2 (0.044) 4 (0.072) 8 (0.108) 2 (0.10) 16 (6.550)
ms4760-10 1 (7:2) 2 (0.027) 2 (0.810)
ms4760-11 3 (5:6) 5 (0.067) 1 (0.05) 6 (2.450)
ms4760-12 1 (8:2) 7 (0.094) 7 (2.860)
ms4760-13 2 (5:4) 1 (0.013) 1 (0.409)
ms4760-14 3 (6:6) 1 (0.013) 1 (0.409)
ms4760-15 3 (5:6) 2 (0.027) 2 (0.810)
ms4760-16 2 (8:4) 5 (0.100) 5 (2.040)
ms4760-17 5 (5:10) 1 (0.05) 1 (0.409)
ms4760-18 2 (7:4) 1 (0.013) 1 (0.05) 2 (0.810)
ms4760-19 1 (6:2) 1 (0.05) 2 (0.409)
    Hed 0.47 0.57 0.70 0.86 0.88 0.79
a

The ms4760-2 (one DNNND sequence), ms4760-4 (three DNNND repeats), and ms4760-8 (three DNNND repeats) genotypes reported elsewhere (8) were not found in this study.

b

His/Asp ratios of ≥1 are in boldface type.

c

n, number of isolates tested.

d

The expected He was calculated by using the formula He = [n/(n − 1)](1 − Σpi2), where n is the number of samples genotyped for that locus and pi is the frequency of the ith allele. Statistical analysis was done with the chi square test, and a P value of <0.05 was considered significant. DNA sequence polymorphisms (nucleotide diversity per site; haplotype [gene] diversity and minimum number of recombination events between sites) were estimated with DnaSP ver. 4. 10. 9 (15).

The number of DNNND repeats varied from one to five, and two repeats were more common (45.9%, n = 244) among the isolates (Fig. 3A). The distribution of isolates with different DNNND repeats exhibited a regional bias (Fig. 3B). Significantly larger numbers of isolates from the A & N Islands, Assam, and Orissa (areas of high CQ and SP resistance) were found to contain a higher number of DNNND repeats compared to those from UP and MP (areas with relatively low CQ and SP resistance; 1-3, 13, 14). However, we have observed that isolates with increased numbers of DNNND repeats also contained a higher number of mutations in the P. falciparum CQ resistance transporter (P < 0.05) (data not shown). This indicates that there could be an association or relationship between the mutations of these two genes. The exact reason for this geographic variation in Pfnhe-1 is not known and requires further investigation. Earlier, Ferdig et al. (8) found a statistically significant association between the number of DNNND repeats and the level of QN resistance. Although it may not directly correlate with the clinical outcome, the number of DNNND repeats may indirectly influence QN responsiveness, as it can influence the His/Asp ratio of the C-terminal domain of Pfnhe-1 (7). The His/Asp ratio can affect the cytosolic pH of the parasite through interactions with other loci and thus the exchange of Na+ and H+ and probably the QN response (7). The example shown in the literature is the ms4760-1 genotype-containing parasite showing a higher level of QN resistance, as this genotype contains a higher His/Asp ratio (7:4) compared to the QN-sensitive parasite bearing the genotype ms4760-5 with a His/Asp ratio of 5:8 (7, 8). In this context, only 6.5% (n = 244) of the Indian isolates contained the ms4760-1 genotype (Table 1). Indeed, another genotype, ms4760-18, was also found to contain the same His/Asp ratio, which was present in two isolates only. Thus, there were a total of 18 (7.38%, total n = 244) isolates with a 7:4 His/Asp ratio, which could follow the pattern of QN responsiveness described by Bennett et al. (7).

FIG. 3.

FIG. 3.

Distribution of DNNND repeats among all of the Indian P. falciparum isolates used in this study (A) and regionwise (B). n, number of isolates.

Our findings of more allelic diversity among the isolates from Assam (12 genotypes, He = 0.86), Orissa (10 genotypes, He = 0.88), and the A & N Islands (6 genotypes, He = 0.70) compared to the isolates from MP (5 genotypes, He = 0.47) and UP (3 genotypes, He = 0.57) are in agreement with reports on the mutations in the markers associated with other drug resistance in these areas (2, 3, 14). Besides, the rates of malaria transmission are also higher in Assam, Orissa, and the A & N Islands compared to those in MP and UP (16). Furthermore, the degree of He (∼0.79) at the ms4760 locus of the Pfnhe-1 gene is also comparable to the He observed at other microsatellite loci in P. falciparum (5, 12, 18). From a total of 378 nucleotide positions considered in the alignment, 42 were polymorphic (18 singleton variable and 24 parsimony informative) and 178 were monomorphic sites. The haplotype (gene) diversity was 0.90 ± 0.062 (standard deviation). The nucleotide diversity per site was found to be 0.0515 ± 0.0081, and the nucleotide diversity with Jukes-and-Cantor correction was 0.054. The minimum number of recombination events observed was four.

The genetic variations observed in the parasite populations in India may provide useful baseline data for future studies on this promising drug resistance locus. Studies using neutral microsatellite polymorphisms flanking the Pfnhe-1 gene along with other loci in the genome are required to understand the basis of this genetic polymorphism whether it is due to genetic drift or selective pressure.

Nucleotide sequence accession numbers. The nucleotide sequences determined in this study have been assigned accession numbers DQ864466 to DQ864486, EF123065, EF123066, and EF442125 to EF442128.

Acknowledgments

S.V. and M.T.A. acknowledge the Council of Scientific and Industrial Research (CSIR) for senior research fellowships. Financial support for this work granted by the Indian Council of Medical Research (ICMR) and the Department of Biotechnology (DBT), Government of India, is acknowledged. We are also grateful to the bioinformatics facilities of the Biotechnology Information System (BTIS).

Footnotes

Published ahead of print on 8 October 2007.

REFERENCES

  • 1.Ahmed, A., D. Bararia, S. Vinayak, M. Yameen, S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma. 2004. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob. Agents Chemother. 48:879-889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ahmed, A., M. K. Das, V. Dev, M. A. Saifi, Wajihullah, and Y. D. Sharma. 2006. Quadruple mutations in dihydrofolate reductase of Plasmodium falciparum isolates from Car Nicobar Island, India. Antimicrob. Agents Chemother. 50:1546-1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ahmed, A., V. Lumb, M. K. Das, V. Dev, Wajihullah, and Y. D. Sharma. 2006. Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India. Antimicrob. Agents Chemother. 50:3934-3938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Alam, M. T., H. Bora, P. K. Bharti, M. A. Saifi, M. K. Das, V. Dev, A. Kumar, N. Singh, A. P. Dash, B. Das, Wajihullah, and Y. D. Sharma. 2007. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Antimicrob. Agents Chemother. 51:857-863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Anderson, T. J., X. Z. Su, A. Roddam, and K. P. Day. 2000. Complex mutations in a high proportion of microsatellite loci from the protozoan parasite Plasmodium falciparum. Mol. Ecol. 9:1599-1608. [DOI] [PubMed] [Google Scholar]
  • 6.Baird, J. K. 2005. Effectiveness of antimalarial drugs. N. Engl. J. Med. 352:1565-1577. [DOI] [PubMed] [Google Scholar]
  • 7.Bennett, T. N., J. Patel, M. T. Ferdig, and P. D. Roepe. 2007. Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance. Mol. Biochem. Parasitol. 153:48-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ferdig, M. T., R. A. Cooper, J. Mu, B. Deng, D. A. Joy, X. Z. Su, and T. E. Wellems. 2004. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52:985-997. [DOI] [PubMed] [Google Scholar]
  • 9.Gardner, M. J., S. J. Shallom, J. M. Carlton, S. L. Salzberg, V. Nene, A. Shoaibi, A. Ciecko, J. Lynn, M. Rizzo, B. Weaver, B. Jarrahi, M. Brenner, B. Parvizi, L. Tallon, A. Moazzez, D. Granger, C. Fujii, C. Hansen, J. Pederson, T. Feldblyum, J. Peterson, B. Suh, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, O. White, L. M. Cummings, H. O. Smith, M. D. Adams, J. C. Venter, D. J. Carucci, S. L. Hoffman, and C. M. Fraser. 2002. Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14. Nature 419:531-534. [DOI] [PubMed] [Google Scholar]
  • 10.Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98. [Google Scholar]
  • 11.Hyde, J. E. 2005. Drug-resistant malaria. Trends Parasitol. 21:494-498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Leclerc, M. C., P. Durand, T. de Meeus, V. Robert, and F. Renaud. 2002. Genetic diversity and population structure of Plasmodium falciparum isolates from Dakar, Senegal, investigated from microsatellite and antigen determinant loci. Microbes Infect. 4:685-692. [DOI] [PubMed] [Google Scholar]
  • 13.Misra, S. P. 1999. In-vivo resistance to chloroquine and sulfa-pyrimethamine combination in Plasmodium falciparum in India. Proc. Natl. Acad. Sci. India 66:123-128. [Google Scholar]
  • 14.Mittra, P., S. Vinayak, H. Chandawat, M. K. Das, N. Singh, S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma. 2006. Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India. J. Infect. Dis. 193:1304-1312. [DOI] [PubMed] [Google Scholar]
  • 15.Rozas, J., J. C. Sanchez-DelBarrio, X. Messeguer, and R. Rozas. 2003. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496-2497. [DOI] [PubMed] [Google Scholar]
  • 16.Sharma, V. P. 1999. Current scenario of malaria in India. Parasitologia 41:349-353. [PubMed] [Google Scholar]
  • 17.Valderramos, S. G., and D. A. Fidock. 2006. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 27:594-601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Vinayak, S., P. Mittra, and Y. D. Sharma. 2006. Wide variation in microsatellite sequences within each Pfcrt mutant haplotype. Mol. Biochem. Parasitol. 147:101-108. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES